Providing strategic clarity to navigate the IVD pathway with confidence.
Helping innovation thrive and improving patient’s lives by enabling strategic, compliant pathways to market.
To be the first strategic pitstop, guiding every IVD manufacturer to market success globally.


EmRQ Limited (formerly Barringer Associates) was founded in May 2024 by Emma Barringer, who has had a seasoned career navigating the full IVD pathway, with a focus on clinical and QARA. During that time, she observed consistent gaps and challenges that can slow innovation, increase risk, or complicate funding and scaling.
Today, EmRQ draws on this personal expertise, alongside trusted industry partners and seasoned professionals to provide strategic insight and decision support for IVD manufacturers. Our goal is to help leadership teams and investors identify risks early, make informed decisions and safeguard timelines, funding and company valuation.
We are passionate about supporting innovators on their device journey. Often, the most critical issues are the ones you don’t see coming and that’s where EmRQ brings clarity. With experience in public health care laboratories and commercial IVD environments, we understand the importance of getting innovations safely and efficiently to patients.

I’m Emma Barringer, an IVD consultant with 30 years of experience in the clinical, regulatory, quality and commercial areas across the In Vitro Diagnostic and Medical Device sectors. I have a deep understanding of the entire device pathway, from early development and regulatory strategy to clinical validation and post-market surveillance, and I bring this experience to support leadership teams and investors in making confident, strategic decisions.
Currently, I serve as Managing Director at EMRQ Limited, guiding IVD companies through complex regulatory, quality, and clinical challenges. I focus on strategic de-risking, readiness assessments, and board-level insight, helping organisations navigate critical decisions that affect timelines, funding, and long-term value.
Throughout my career, I’ve held senior leadership roles, including Head of QARA & Clinical Affairs at Novacyt Group, where I led regulatory and clinical activities across multiple sites. I specialise in strategic regulatory planning, clinical study oversight, and ensuring compliance with industry standards such as ISO and IVDR.
I am passionate about unlocking potential in people, teams, and organisations, providing clear, strategic guidance that ensures compliance success while supporting innovation and growth.